Total Payments
$172,651
2024 Payments
$335.80
Companies
21
Transactions
278
Medicare Patients
1,764
Medicare Billing
$307,237
Payment Breakdown by Category
Other$158,257 (91.7%)
Travel$8,806 (5.1%)
Food & Beverage$5,345 (3.1%)
Education$243.07 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $158,257 | 112 | 91.7% |
| Travel and Lodging | $8,806 | 30 | 5.1% |
| Food and Beverage | $5,345 | 131 | 3.1% |
| Education | $243.07 | 5 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| United Therapeutics Corporation | $115,669 | 130 | $0 (2024) |
| Gilead Sciences, Inc. | $53,894 | 67 | $0 (2021) |
| Actelion Pharmaceuticals US, Inc. | $2,238 | 34 | $0 (2024) |
| GENZYME CORPORATION | $112.29 | 5 | $0 (2024) |
| GlaxoSmithKline, LLC. | $111.43 | 7 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $98.90 | 6 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $81.10 | 8 | $0 (2019) |
| Mylan Specialty L.P. | $71.70 | 3 | $0 (2023) |
| Amgen Inc. | $54.52 | 3 | $0 (2023) |
| Genentech USA, Inc. | $54.46 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $335.80 | 5 | Actelion Pharmaceuticals US, Inc. ($199.18) |
| 2023 | $376.29 | 18 | Mylan Specialty L.P. ($71.70) |
| 2022 | $277.43 | 4 | Actelion Pharmaceuticals US, Inc. ($152.05) |
| 2021 | $14,756 | 16 | United Therapeutics Corporation ($14,741) |
| 2020 | $9,036 | 17 | United Therapeutics Corporation ($8,935) |
| 2019 | $32,020 | 45 | United Therapeutics Corporation ($31,769) |
| 2018 | $43,658 | 61 | United Therapeutics Corporation ($31,023) |
| 2017 | $72,192 | 112 | Gilead Sciences Inc ($41,438) |
All Payment Transactions
278 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/23/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Education | In-kind items and services | $18.09 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/26/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $110.19 | General |
| Category: Cardiology | ||||||
| 08/20/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Education | In-kind items and services | $88.99 | General |
| Category: Cardiology | ||||||
| 02/16/2024 | United Therapeutics Corporation | — | Food and Beverage | In-kind items and services | $95.56 | General |
| 01/11/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.97 | General |
| Category: Immunology | ||||||
| 12/13/2023 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: PAH | ||||||
| 12/11/2023 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $20.71 | General |
| Category: Respiratory | ||||||
| 11/29/2023 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $25.74 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 11/03/2023 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: Rare Disease | ||||||
| 10/18/2023 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $26.35 | General |
| Category: Cardiology | ||||||
| 10/16/2023 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: Respiratory | ||||||
| 10/16/2023 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: Inflammation | ||||||
| 10/10/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: Immunology | ||||||
| 08/21/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $32.00 | General |
| Category: Immunology | ||||||
| 08/09/2023 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $19.58 | General |
| Category: Inflammation | ||||||
| 08/03/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: RESPIRATORY | ||||||
| 07/27/2023 | Pharming Healthcare, Inc. | RUCONEST (Biological) | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: BIOLOGIC | ||||||
| 07/13/2023 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 06/06/2023 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: Inflammation | ||||||
| 05/10/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: IMMUNOLOGY | ||||||
| 04/17/2023 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $22.96 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 04/13/2023 | Sandoz Inc. | TREPROSTINIL (Drug) | Food and Beverage | In-kind items and services | $28.27 | General |
| Category: PULMONARY ARTERIAL HYPERTENSION | ||||||
| 04/12/2023 | Bayer Healthcare Pharmaceuticals Inc. | Adempas (Drug) | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: Cardio-pulmonary | ||||||
| 11/17/2022 | Getinge USA Sales, LLC | Cardiohelp (Device) | Food and Beverage | In-kind items and services | $22.88 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/12/2022 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $75.06 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 344 | 535 | $132,166 | $55,472 |
| 2022 | 11 | 356 | 574 | $147,696 | $59,508 |
| 2021 | 10 | 445 | 706 | $194,264 | $76,360 |
| 2020 | 12 | 619 | 1,062 | $300,300 | $115,897 |
Total Patients
1,764
Total Services
2,877
Medicare Billing
$307,237
Procedure Codes
48
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 48 | 109 | $43,927 | $17,991 | 41.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 63 | 128 | $27,392 | $11,676 | 42.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 57 | 94 | $17,578 | $8,596 | 48.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 35 | 35 | $12,565 | $4,392 | 35.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 25 | 31 | $7,812 | $4,030 | 51.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 20 | 20 | $7,260 | $3,397 | 46.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 33 | 50 | $9,150 | $3,054 | 33.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 17 | 17 | $4,947 | $1,827 | 36.9% |
| 94618 | Test for exercise-induced lung stress | Facility | 2023 | 11 | 16 | $736.00 | $225.55 | 30.6% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 12 | 12 | $288.00 | $112.08 | 38.9% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 11 | 11 | $319.00 | $88.11 | 27.6% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 12 | 12 | $192.00 | $83.28 | 43.4% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 56 | 157 | $67,471 | $26,971 | 40.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 67 | 130 | $27,196 | $10,186 | 37.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 51 | 66 | $12,582 | $5,946 | 47.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 28 | 28 | $10,238 | $4,304 | 42.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 41 | 75 | $12,306 | $4,153 | 33.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 26 | 26 | $7,566 | $3,355 | 44.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 12 | 14 | $3,528 | $1,947 | 55.2% |
| 31500 | Emergent insertion of breathing tube into windpipe using an endoscope | Facility | 2022 | 11 | 11 | $2,929 | $1,251 | 42.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 12 | 15 | $2,268 | $993.14 | 43.8% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2022 | 18 | 18 | $408.00 | $160.71 | 39.4% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2022 | 17 | 17 | $503.00 | $129.44 | 25.7% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2022 | 17 | 17 | $701.00 | $112.48 | 16.0% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 88 | 244 | $108,092 | $41,945 | 38.8% |
About Dr. Daniel Gorbett, MD
Dr. Daniel Gorbett, MD is a Critical Care Medicine healthcare provider based in Dublin, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/30/2008. The National Provider Identifier (NPI) number assigned to this provider is 1487816518.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Gorbett, MD has received a total of $172,651 in payments from pharmaceutical and medical device companies, with $335.80 received in 2024. These payments were reported across 278 transactions from 21 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($158,257).
As a Medicare-enrolled provider, Gorbett has provided services to 1,764 Medicare beneficiaries, totaling 2,877 services with total Medicare billing of $307,237. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Ad
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Pulmonary Disease
- Location Dublin, OH
- Active Since 06/30/2008
- Last Updated 06/02/2022
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1487816518
Products in Payments
- ORENITRAM (Drug) $32,574
- Letairis (Drug) $31,386
- NONE (Drug) $25,625
- REMODULIN (Drug) $18,711
- TYVASO (Drug) $6,328
- OPSUMIT (Drug) $246.63
- UPTRAVI (Drug) $238.46
- OPSUMIT MACITENTAN (Drug) $131.92
- Adempas (Drug) $98.90
- DUPIXENT (Biological) $74.28
- YUPELRI (Drug) $71.70
- TEZSPIRE (Biological) $55.18
- TRELEGY ELLIPTA (Drug) $52.01
- Obstructive Sleep Apnea Device or Hospital Respiratory Equipment (Device) $47.72
- BREO (Drug) $41.92
- DUPIXENT (Drug) $38.01
- Esbriet (Biological) $38.00
- OFEV (Drug) $33.97
- LONHALA MAGNAIR (Drug) $30.92
- TREPROSTINIL (Drug) $28.27
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Dublin
Vishal Agrawal, M.d, M.D
Critical Care Medicine — Payments: $4,401
Critical Care Medicine $4,401
Tyler Anderson, Md, MD
Critical Care Medicine — Payments: $3,552
Critical Care Medicine $3,552
Dylan Wirtz, M.d, M.D
Critical Care Medicine — Payments: $1,748
Critical Care Medicine $1,748
Ayn Vincent Bayani, M.d, M.D
Critical Care Medicine — Payments: $547.48
Critical Care Medicine $547.48
Krishnamurthy Umapathy, Md, MD
Critical Care Medicine — Payments: $27.58
Critical Care Medicine $27.58
Sindhu Mukku, Md, MD
Critical Care Medicine — Payments: $16.50
Critical Care Medicine $16.50